Aged Garlic Extract
Aged Garlic Extract (AGE) is the most clinically studied form of garlic supplementation, produced by aging sliced garlic in ethanol for 20+ months. This process converts unstable allicin into stable, bioavailable organosulfur compounds — primarily S-allylcysteine (SAC) and S-allylmercaptocysteine (SAMC). AGE has the strongest evidence base of any garlic form for blood pressure reduction: a 2020 Cochrane-quality meta-analysis of 12 RCTs (Ried et al.) found AGE reduces systolic BP by 8-10 mmHg in hypertensive individuals, comparable to first-line antihypertensives. In TRT contexts, garlic extract is relevant because testosterone increases erythropoiesis and hematocrit — cardiovascular risk factors that AGE can partially offset via BP reduction, improved arterial compliance, and reduced coronary artery calcification. The 2016 Matsumoto trial demonstrated AGE reduced coronary plaque progression in metabolic syndrome patients. Also shows modest LDL reduction and immune support via NK cell activation.
Current literature links
Evidence
No score yet
Safety
Unknown safety profile
Clinical Status
Multiple RCTs and meta-analyses; OTC supplement
Last Sync
Not synced yet
Last Reviewed
Not reviewed yet
Dosing
Set height & weight in Settings to see your dose.
Pharmacology
Evidence Score
Plain-English Snapshot
Aged Garlic Extract is currently categorized as a supplement compound.
Evidence scoring has not been fully computed yet, so interpret this profile as preliminary.
Safety scoring is incomplete. Start conservatively and monitor carefully.
Core mechanism
S-allylcysteine inhibits ACE and activates eNOS → vasodilation and BP reduction; polysulfides activate TRPA1/H2S signaling; organosulfur compounds reduce oxidative stress and inflammation
Practical Context
Strongest current signals
No indexed study summaries yet.